Clinical validity of phenotype-driven analysis software PhenoVar as a diagnostic aid for clinical geneticists in the interpretation of whole-exome sequencing data

PurposeWe sought to determine the diagnostic yield of whole-exome sequencing (WES) combined with phenotype-driven analysis of variants in patients with suspected genetic disorders.MethodsWES was performed on a cohort of 51 patients presenting dysmorphisms with or without neurodevelopmental disorders of undetermined etiology. For each patient, a clinical geneticist reviewed the phenotypes and used the phenotype-driven analysis software PhenoVar (http://phenovar.med.usherbrooke.ca/) to analyze WES variants. The prioritized list of potential diagnoses returned was reviewed by the clinical geneticist, who selected candidate variants to be confirmed by segregation analysis. Conventional analysis of the individual variants was performed in parallel. The resulting candidate variants were subsequently reviewed by the same geneticist, to identify any additional potential diagnoses.ResultsA molecular diagnosis was identified in 35% of the patients using the conventional analysis, and 17 of these 18 diagnoses were independently identified using PhenoVar. The only diagnosis initially missed by PhenoVar was rescued when the optional “minimal phenotypic cutoff” filter was omitted. PhenoVar reduced by half the number of potential diagnoses per patient compared with the conventional analysis.ConclusionPhenotype-driven software prioritizes WES variants, provides an efficient diagnostic aid to clinical geneticists and laboratories, and should be incorporated in clinical practice.

[1]  Allyn McConkie-Rosell,et al.  The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders , 2013, Genetics in Medicine.

[2]  Hui Yang,et al.  Phenolyzer: phenotype-based prioritization of candidate genes for human diseases , 2015, Nature Methods.

[3]  Marcel H. Schulz,et al.  Clinical diagnostics in human genetics with semantic similarity searches in ontologies. , 2009, American journal of human genetics.

[4]  Michael Brudno,et al.  PhenomeCentral: A Portal for Phenotypic and Genotypic Matchmaking of Patients with Rare Genetic Diseases , 2015, Human mutation.

[5]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[6]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[7]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[8]  Xuan Yuan,et al.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders , 2014, Science Translational Medicine.

[9]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[10]  Alejandro Sifrim,et al.  Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.

[11]  S. Batzoglou,et al.  Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.

[12]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[13]  Damian Smedley,et al.  Improved exome prioritization of disease genes through cross-species phenotype comparison , 2014, Genome research.

[14]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[15]  P. Jacques,et al.  Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing , 2016, Orphanet Journal of Rare Diseases.

[16]  Joshua L. Deignan,et al.  A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories , 2016, Genetics in Medicine.

[17]  Karynne E. Patterson,et al.  The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities. , 2015, American journal of human genetics.

[18]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[19]  M. Hurles,et al.  Extreme Growth Failure is a Common Presentation of Ligase IV Deficiency , 2013, Human mutation.

[20]  B. Peters,et al.  Truncating mutations of MAGEL2cause Prader-Willi phenotypes and autism , 2013, Nature Genetics.

[21]  Hugo Larochelle,et al.  PhenoVar: a phenotype-driven approach in clinical genomics for the diagnosis of polymalformative syndromes , 2014, BMC Medical Genomics.

[22]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[23]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[24]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[25]  Michael R. Speicher,et al.  A survey of tools for variant analysis of next-generation genome sequencing data , 2013, Briefings Bioinform..

[26]  Peter N. Robinson,et al.  Phenotype-driven strategies for exome prioritization of human Mendelian disease genes , 2015, Genome Medicine.

[27]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[28]  J. Rivière,et al.  Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.

[29]  J. Rosenfeld,et al.  The phenotypic spectrum of Schaaf-Yang syndrome – 18 new affected individuals from 14 families , 2016, Genetics in Medicine.

[30]  Brett J. Kennedy,et al.  Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families. , 2014, American journal of human genetics.

[31]  I. Verma,et al.  Global burden of genetic disease and the role of genetic screening. , 2015, Seminars in fetal & neonatal medicine.